Hormonal dysregulation is another contributing factor, as obesity is associated with increased leptin, a pro‐tumorigenic hormone, and decreased adiponectin, an anti‐tumorigenic hormone, which alters immune responses and tumor growth dynamics (Figure 1). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.